fig2
![Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation](https://image.oaes.cc/2af25a41-f32c-4695-8dec-a83b3410da79/2827.fig.2.png)
Figure 2. A: Cumulative incidence of recurrent hepatocellular carcinoma according to HBsAg status after liver transplantation; B: correlation between time of hepatocellular carcinoma recurrence and HBsAg seroreversion after liver transplantation